β

Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders

Federal University of Rio Grande do Norte (UFRN)

5 Trials1 Paper

Sponsored Trials

3
CompletedII

Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression

Start Date
October 9, 2023
Compounds
DMT
CompletedI

Safety and Tolerability of DMT in Healthy Adults

Start Date
April 26, 2023
Compounds
DMT, Placebo
CompletedI, II

Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression

Start Date
February 1, 2014
Compounds
Ayahuasca, Placebo

Collaborated Trials

2
CompletedI

Clinical Study of DMT in Healthy Adults

Start Date
June 1, 2022
Compounds
DMT
Unknown statusNA

Naturalistic Study of Ketamine in the Treatment of Depression

Start Date
May 1, 2021
Compounds
Ketamine

Research Papers

1
Open Accessindividual

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.

This secondary analysis of a double-blind, parallel-arm, randomised placebo-controlled trial (n=29) investigates the impact of ayahuasca on suicidality (SI) in individuals with treatment-resistant depression (TRD). It found that ayahuasca may show potential as a fast-acting and innovative intervention for SI, but didn't find significant results (only a trend with a large effect size). This is the first study to investigate the use of ayahuasca for SI.

Published
November 19, 2019
Journal
Frontiers in Pharmacology
Authors
Araújo, D. B., Zeifman, R. J., Palhano-Fontes, F., Hallak, J. E., Arcoverde, E., Maia-de-Oliveira, J. P.

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.